Study casts doubt on routine Helicobacter pylori testing
This article was originally published in Clinica
Routinely testing for the Helicobacter pylori bacterium in patients with dyspepsia at primary care does not help in the diagnosis of peptic ulcers. This is the conclusion of a Dutch study, which also found that testing is only useful in patients at high risk of peptic ulcer disease and that these patients can be identified by asking three simple questions during a consultation.
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.